Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Olivier Lyon Caen"'
Autor:
Helmi M'Kada, Hugo Perazzo, Mona Munteanu, Yen Ngo, Nittia Ramanujam, Bruno Fautrel, Françoise Imbert-Bismut, Vlad Ratziu, Ina Schuppe-Koistinen, Véronique Leblond, Jean Yves Delattre, Yves Samson, Olivier Lyon Caen, François Bricaire, David Khayat, Charles Pierrot-Deseilligny, Serge Herson, Zahir Amoura, Patrick Tilleul, Olivier Deckmyn, Pierre Coriat, Vincent Nicolas Delpech, Philippe Boulogne, Dominique Bonnefont-Rousselot, Thierry Poynard, Drug Induced Liver Injury Groupe Hospitalier Pitié-Salpêtrière Group, Safer and Faster Evidence-based Translation Consortium
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e42418 (2012)
Identification of drug-induced liver disease (DILI) is difficult, even among hospitalized patients. The aim of this pilot study was to assess the impact of a specific strategy for DILI screening.We prospectively compared the number of acute DILI case
Externí odkaz:
https://doaj.org/article/c30be209d45e4384a65d4c5b684e4df5
Autor:
Julien Carricaburu, Olivier Lyon-Caen
Publikováno v:
Médecine des Maladies Métaboliques. 16:233-236
Autor:
Agnès Bellanger, Christine Lebrun-Frenay, Valerie Touitou, Olivier Gout, Olivier Lyon-Caen, Ayman Tourbah, Damien Galanaud, Frédéric Sedel, Caroline Papeix
Publikováno v:
Multiple Sclerosis and Related Disorders
Multiple Sclerosis and Related Disorders, 2015, 4 (2), pp.159-69
Multiple Sclerosis and Related Disorders, 2015, 4 (2), pp.159-69
International audience; No drug has been found to have any impact on progressive multiple sclerosis (MS). Biotin is a vitamin acting as a coenzyme for carboxylases involved in key steps of energy metabolism and fatty acids synthesis. Among others, bi
Autor:
Yves Agid, Catherine Lubetzki, Emmanuelle Waubant, Jean-Paul Nguyen, Pierre Jedynak, Olivier Lyon-Caen, Stéphane Palfi, Bruno Stankoff, Tomasz Mandat, Hassan Hosseini, Pierre Cesaro
Publikováno v:
Neurosurgery. 70:66-69
BACKGROUND Surgical options of multiple sclerosis (MS) tremor treatment are limited and narrowed to thalamotomy or deep brain stimulation of the thalamic nucleus ventralis intermedius. Lack of qualification protocol frequently results in poor outcome
Autor:
Mads Ravnborg, Olivier Lyon-Caen, Antonio Garcia-Merino, Gilles Edan, David W. Bates, Hans Peter Hartung, Christian Sindic, Ernst W. Radü, Hans H. Hirsch, Takahiko Saida, Eva Havrdova, Ralf Gold, Mefkure Eraksoy, Per Soelberg Sørensen, Marcelo Kremenchutzky, David B. Clifford, Paul O'Connor, Eugene O. Major, John King, Nikolaos Grigoriadis, Carlo Pozzilli, Jan Hillert, Karl Vass, Stephen L. Hauser, Howard L. Weiner, Reinhard Hohlfeld, Michel Clanet, Ludwig Kappos, Ariel Miller
Publikováno v:
Kappos, L, Bates, D, Edan, G, Eraksoy, M, Garcia-Merino, A, Grigoriadis, N, Hartung, H-P, Havrdová, E, Hillert, J, Hohlfeld, R, Kremenchutzky, M, Lyon-Caen, O, Miller, A, Pozzilli, C, Ravnborg, M, Saida, T, Sindic, C, Vass, K, Clifford, D B, Hauser, S, Major, E O, O'Connor, P W, Weiner, H L, Clanet, M, Gold, R, Hirsch, H H, Radü, E-W, Sørensen, P S & King, J 2011, ' Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring ', Lancet Neurology, vol. 10, no. 8, pp. 745-58 . https://doi.org/10.1016/S1474-4422(11)70149-1
The Lancet Neurology, Vol. 10, no. 8, p. 745-758 (2011)
ResearcherID
The Lancet Neurology, Vol. 10, no. 8, p. 745-758 (2011)
ResearcherID
Natalizumab, a highly specific α4-integrin antagonist, is approved for treatment of patients with active relapsing-remitting multiple sclerosis (RRMS). It is generally recommended for individuals who have not responded to a currently available first
Autor:
Lamiae, Grimaldi-Bensouda, Annick, Alpérovitch, Gérard, Besson, Christophe, Vial, Jean-Marie, Cuisset, Caroline, Papeix, Olivier, Lyon-Caen, Jacques, Benichou, Michel, Rossignol, V, Pautot
Publikováno v:
American Journal of Epidemiology. 174:326-335
The role of influenzalike illnesses and influenza vaccination in the development of Guillain-Barré syndrome (GBS), particularly the role of A/H1N1 epidemics and A/H1N1 vaccination, is debated. Data on all incident GBS cases meeting the Brighton Coll
Autor:
Raffaella Lucanto, Monique Plaza, Odile Dubourg, Olivier Bonnot, Olivier Lyon-Caen, Frédéric Sedel, Nathalie Kelley, David Cohen, Matthew J. Fraidakis, Dominique Chauvin
Publikováno v:
CNS Spectrums. 15:231-237
Cerebrotendinous xanthomatosis (CTX) is a rare inborn disorder of sterol storage with autosomal recessive inheritance and a variable clinical presentation. We describe two siblings with an early psychiatric presentation of CTX-associated attention-de
Publikováno v:
La Presse Médicale. 39:381-388
Several drugs are now available to treat multiple sclerosis. MS treatment has included immunomodulatory agents for 15 years; monoclonal antibody therapies have recently been added. IFN beta and Glatiramer acetate are effective in reducing relapses an
Publikováno v:
Journal of Inherited Metabolic Disease. 30:855-864
Spastic paraparesis is a general term describing progressive stiffness and weakness in the lower limbs caused by pyramidal tract lesions. This clinical situation is frequently encountered in adult neurology. The diagnostic survey is usually limited t
Publikováno v:
Revue Neurologique. 163:884-896
Hereditary metabolic diseases may appear during adolescence or young adulthood, revealed by an apparently unexplained neurological or psychiatric disorder. Certain metabolic diseases respond to specific treatments and should be identified early, part